Showing 1 - 2 results of 2 for search 'Alessandro Follador', query time: 0.01s Refine Results
  1. 1
    Carboplatin, etoposide, atezolizumab, and bevacizumab in the first-line treatment of patients with extensive stage small-cell lung cancer: the GOIRC-01-2019 CeLEBrATE study

    Carboplatin, etoposide, atezolizumab, and bevacizumab in the first-line treatment of patients with extensive stage small-cell lung cancer: the GOIRC-01-2019 CeLEBrATE study by Marcello Tiseo, Corrado Ficorella, Andrea Ardizzoni, Carlo Genova, Francesca Mazzoni, Giuseppe Lamberti, Luca Boni, Ida Colantonio, Alessandro Leonetti, Saverio Cinieri, Andrea Bonetti, Michele Tognetto, Federica Bertolini, Alessandro Follador, Elisa Andrini, Antonio Frassoldati, Francesco Gelsomino, Giulia Pasello, Karim Rihawi, Ferdinando Riccardi, Donatella Giardina, Matteo Brighenti

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program

    Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program by Marina Chiara Garassino, Lucio Crinò, Annamaria Catino, Andrea Ardizzoni, Enrico Cortesi, Federico Cappuzzo, Paola Bordi, Luana Calabrò, Fausto Barbieri, Antonio Santo, Giuseppe Altavilla, Francesca Ambrosio, Enrico Mini, Enrico Vasile, Floriana Morgillo, Alessandro Scoppola, Carmelo Bengala, Alessandro Follador, Natale Tedde, Diana Giannarelli, Giuseppe Lo Russo, Fabiana Vitiello

    Published 2018-11-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: